Serotonin News and Research

Latest Serotonin News and Research

Scientists map novel structure of so-called 'neurotransmitter: sodium symporter’

A novel structure of a so-called 'neurotransmitter: sodium symporter’ has been mapped at the University of Copenhagen.

6 Mar 2020

Researchers uncover novel neurotransmitter system in the brain

Neurotransmitters are chemicals that transmit signals between neurons or from neurons to other cells. They interact with specific receptors found in the brain of humans and animals, controlling a variety of biological processes, e.g. fear, anger, pleasure, memory, energy, appetite and sleep.

5 Mar 2020

Antidepressant shows promise in helping men with recurrent prostate cancer

An antidepressant in use for decades, repurposed to fight prostate cancer, shows promise in helping patients whose disease has returned following surgery or radiation, a pilot study at USC shows.

4 Mar 2020

Experimental drug offers hope for improving movement symptoms of Parkinson's

Results from a study looking at an experimental drug to tackle the debilitating side effect of dyskinesia, have offered hope that it may have potential as a future treatment for people with Parkinson's.

2 Mar 2020

Using 'mini-brains' to detect harmful neurodevelopmental effects of antidepressant

Researchers at Johns Hopkins Bloomberg School of Public Health have demonstrated the use of stem-cell-derived "mini-brains" to detect harmful side effects of a common drug on the developing brain.

21 Feb 2020

Using a simple model to study how serotonin modulates behavior

In popular experience the story of how serotonin modulates the brain might seem simple: pop an antidepressant, serotonin levels go up, mood improves. But neuroscientists acknowledge how little they know about how the neurotransmitter affects circuits and behavior in the incredibly complex human brain.

20 Feb 2020

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

As out-of-pocket costs go up for drugs for the neurologic disorders Alzheimer's disease, peripheral neuropathy and Parkinson's disease, people are less likely to take the drugs as often as their doctors prescribed, according to a study funded by the American Academy of Neurology and published in the February 19, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Feb 2020

BPA-free plastic products aren't safe for people to use, scientists warn

Using "BPA-free" plastic products could be as harmful to human health -- including a developing brain -- as those products that contain the controversial chemical, suggest scientists in a new study led by the University of Missouri and published in the Proceedings of the National Academy of Sciences.

19 Feb 2020

Scientists use toxin from rattlesnake venom for chronic pain

Rattlesnake (Crotalus adamanteus) is the largest venomous snake in North America, reaching 8 feet and weighing up to 10 pounds. In the past, medical experts believe that the toxin in rattlesnake venom, crotoxin, is a promising compound for the treatment of chronic pain.

18 Feb 2020

Depression treatment using AI, brain scans

Artificial intelligence (AI) may be a useful and even essential tool in selecting the best treatment for depression, according to a new study published in the journal Nature Biotechnology on February 2020.

10 Feb 2020

Study sheds new light on genetic relationship between three mood disorders

Researchers shed new light on the genetic relationship between three mood disorders associated with depression--major depression and bipolar disorder types 1 and 2, in a new study in the journal Biological Psychiatry, published by Elsevier.

5 Feb 2020

Shift workers at increased risk for sleep disorders and metabolic syndrome

Shift workers are at a significantly increased risk for sleep disorders and metabolic syndrome, which increases a person's risk for heart disease, stroke and type 2 diabetes mellitus.

3 Feb 2020

Non-hormonal options are effective in treating menopause symptoms

The classic symptoms of menopause – hot flashes, sleeplessness, and vaginal dryness – have typically been treated with estrogen therapy. Studies published today report that non-hormonal options are effective, too.

24 Jan 2020

Gut microbiome linked to behavioral problems in children

Children with behavioral problems may have different compositions in their gut microbiome, with parents playing a major role in how pronounced the differences were, other than the food they provide, a new study suggests.

21 Jan 2020

New analysis method shows how the brain regulates its signals using glutamate

Researchers at Chalmers University of Technology and Gothenburg University in Sweden have achieved something long thought almost impossible - counting the molecules of the neurotransmitter glutamate released when a signal is transferred between two brain cells. With a new analysis method, they showed that the brain regulates its signals using glutamate in more ways than previously realised.

21 Jan 2020

Burnout linked to higher risk for abnormal heart rhythm

A new study published in January 2020 in the European Journal of Preventive Cardiology shows that burnout could really cause your heart to fail as a result of an abnormal heart rhythm called atrial fibrillation (AF).

14 Jan 2020

Researchers study the effects of antidepressants to identify the least harmful drugs

About one in ten women in Québec will suffer from depression during pregnancy. Without treatment, the illness carries risks for both mother and child.

8 Jan 2020

VA researchers find new evidence on the underlying biological causes of anxiety

In the largest genetic study on anxiety to date, VA researchers found new evidence on the underlying biological causes of the disorder.

7 Jan 2020

No clear evidence to determine if psychotherapy or medications are more effective for treating PTSD

A new study that sought to find out whether serotonin reuptake inhibitors or trauma-focused psychotherapy is more effective in treating posttraumatic stress disorder (PTSD) concluded there is insufficient evidence at present to make that determination.

20 Dec 2019

Scientists evaluate mouse models used for developing new treatments for Huntington's disease

Huntington's disease (HD) is an incurable and fatal hereditary disease. Developing disease-modifying drugs to treat patients with HD depends on studying them in animal models. Scientists evaluated the mouse models used for developing new treatments for mood disorders in HD and recommended which of these models are most relevant to their studies.

11 Dec 2019

Serotonin News and Research

Latest Serotonin News and Research

Scientists map novel structure of so-called 'neurotransmitter: sodium symporter’

Researchers uncover novel neurotransmitter system in the brain

Antidepressant shows promise in helping men with recurrent prostate cancer

Experimental drug offers hope for improving movement symptoms of Parkinson's

Using 'mini-brains' to detect harmful neurodevelopmental effects of antidepressant

Using a simple model to study how serotonin modulates behavior

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

BPA-free plastic products aren't safe for people to use, scientists warn

Scientists use toxin from rattlesnake venom for chronic pain

Depression treatment using AI, brain scans

Study sheds new light on genetic relationship between three mood disorders

Shift workers at increased risk for sleep disorders and metabolic syndrome

Non-hormonal options are effective in treating menopause symptoms

Gut microbiome linked to behavioral problems in children

New analysis method shows how the brain regulates its signals using glutamate

Burnout linked to higher risk for abnormal heart rhythm

Researchers study the effects of antidepressants to identify the least harmful drugs

VA researchers find new evidence on the underlying biological causes of anxiety

No clear evidence to determine if psychotherapy or medications are more effective for treating PTSD

Scientists evaluate mouse models used for developing new treatments for Huntington's disease

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Serotonin News and Research

Latest Serotonin News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in